tiprankstipranks
Q BioMed Inc (QBIO)
OTHER OTC:QBIO
US Market
Holding QBIO?
Track your performance easily

Q BioMed (QBIO) Stock Price & Analysis

102 Followers

QBIO Stock Chart & Stats


Financials

Annual

Ownership Overview

<0.01%99.99%
Insiders
Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

QBIO FAQ

What was Q BioMed Inc’s price range in the past 12 months?
Currently, no data Available
What is Q BioMed Inc’s market cap?
Currently, no data Available
When is Q BioMed Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Q BioMed Inc’s earnings last quarter?
Currently, no data Available
Is Q BioMed Inc overvalued?
According to Wall Street analysts Q BioMed Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
    Does Q BioMed Inc pay dividends?
    Q BioMed Inc does not currently pay dividends.
    What is Q BioMed Inc’s EPS estimate?
    Q BioMed Inc’s EPS estimate for its next earnings report is not yet available.
    How many shares outstanding does Q BioMed Inc have?
    Q BioMed Inc has 145,094,530 shares outstanding.
      What happened to Q BioMed Inc’s price movement after its last earnings report?
      Currently, no data Available
      Which hedge fund is a major shareholder of Q BioMed Inc?
      Currently, no hedge funds are holding shares in QBIO
      ---

      Q BioMed Stock Smart Score

      10
      Unlock Smart Score
      1
      2
      3
      4
      5
      6
      7
      8
      9
      10

      Company Description

      Q BioMed Inc

      Q BioMed, Inc. operates as a biomedical acceleration and development company. It focuses on acquiring, licensing, and providing resources to life sciences and healthcare companies. Its products include Strontium 89, QBM-001, Uttroside-B, and MAN 01. The company was founded by Enrique Navas on November 22, 2013 and is headquartered in New York, NY.
      ---
      Similar Stocks
      Company
      Price & Change
      Follow
      Brainstorm Cell Therapeutics
      Actinium Pharmaceuticals
      Citius Pharmaceuticals
      Genprex
      Popular Stocks
      ---
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis